PTEN and breast neoplasm: In contrast to previous papers reporting that promoter methylation of PTEN is a frequent event in breast tumors [64–67], in none of the tumors analyzed in the present study, the PTEN promoter was found to show a methylation status ≥ LOQ (although with 0.5%, the LOQ of the MS-HRM assay was very low).